Biolinerx Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biolinerx ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biolinerx Ltd Today - Breaking & Trending Today

Short Interest in BioLineRx Ltd. (NASDAQ:BLRX) Decreases By 46.6%

BioLineRx Ltd. (NASDAQ:BLRX – Get Free Report) was the recipient of a large decrease in short interest in May. As of May 15th, there was short interest totalling 219,100 shares, a decrease of 46.6% from the April 30th total of 410,600 shares. Based on an average daily volume of 410,600 shares, the short-interest ratio is […] ....

B Riley Wealth Advisors Inc , Rathbones Group , Biolinerx Company Profile , Northrock Partners , Biolinerx Ltd , First Advisors Inc , Allen Mooney Barnes Investment Advisors , Get Free Report , Rock Partners , Wealth Advisors , Riley Wealth Advisors , Barnes Investment Advisors , Values First Advisors , Linerx Ltd , Biolinerx Daily ,

BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD)

BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Ella Sorani , Moran Meir , John Lacey , Jude Children Research Hospital , Biolinerx Ltd , Us Food Drug Administration , Exchange Commission On , Prnewswire Biolinerx Ltd , Washington University School Of Medicine , Jude Children Research Hospital Inc , Lifesci Advisors , Jude Children , Research Hospital , Chief Development Officer , Washington University School , Drug Administration , Sickle Cell Disease Stem Mobilization , Apheresis Using Motixafortide , Private Securities Litigation Reform Act , Exchange Commission , Sci Advisors ,

BioLineRx Ltd. (NASDAQ:BLRX) Q1 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2024 Financial Results Conference Call. All participants are presently in a listen-only mode. ....

United States , John Vandermosten , John Lacey , Gloria Biosciences , Phil Serlin , Ella Sorani , Joe Pantginis , American Society For Apheresis Annual Meeting , Biolinerx Ltd , Corporate Communications , Washington University , Columbia University , Outcomes Research , Exchange Commission , International Society For Pharmacoeconomics , American Society Of Clinical Oncology , Washington University School Of Medicine , Call Transcript May , Biolinerx First Quarter , Results Conference , Investor Relations , Chief Executive Officer , Holly May , Biolinerx United States , Mali Zeevi , Chief Financial ,

BioLineRx : Reports First Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

. ....

United States , Israel General , Philip Serlin , Twitterand Linkedin , Philipa Serlin , Gloria Biosciences , Moran Meir , John Lacey , Gloria Bioscience , Exchange Commission On , Medicaid Services , Lifesci Advisors , Washington University In St , International Society For Pharmacoeconomics , Outcomes Research On , American Society Of Clinical Oncology , Centers For Medicare , Biolinerx Ltd , Securities Exchange , American Society For Apheresis , Columbia University , Washington University School Of Medicine , Ma Ayan Street , Principal Executive Offices , Quarter Ended March , Securities Act ,

BioLineRx Ltd. Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer at American Society of Clinical Oncology

BioLineRx Ltd. Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer at American Society of Clinical Oncology
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Biolinerx Ltd , American Society Of Clinical Oncology , Clinical Oncology , Annual Meeting ,